An unprecedented number of potentially disruptive therapeutic technologies are under development. Forward-looking policies, incentives and infrastructure are needed to harness these advances to provide effective and globally equitable healthcare.
- David J. Ecker
- Clarice D. Aiello
- Michael R. Hayden